A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2006
11/08/2006	CN1857556A Health care composition for strengthening male's immunity and its preparing method
11/08/2006	CN1857513A Chinese medicine composition for strengthening immunity, beautifying and treating skin disease
11/08/2006	CN1857509A Health composition for strengthening women's immunity and its preparing method
11/08/2006	CN1857474A Oral Chinese medicine preparation for replenishing vitamins and trace elements
11/08/2006	CN1857378A Compound wild kiwi tablet and its preparing method
11/08/2006	CN1857365A Chinese medicine injection with antiphlogistic and immuno-suppresive functions and its preparing method
11/08/2006	CN1857350A Immunological function strengthening medicine and health product and their preparing method
11/08/2006	CN1857300A Freeze dried ginseng polysaccharide powder for injection and its preparing process
11/08/2006	CN1857299A New use of mankshood polysaccharide in preventing and treating post-chemotherapy bone marrow arrest
11/08/2006	CN1857289A Dispersed compound tablet of glycyrrhizic acid and glycyrrhizinate and its preparing process
11/08/2006	CN1857277A Suspension spray for treating allergic rhinitis and its preparing method
11/08/2006	CN1857239A Coenzyme Q10 injection emulsion and its preparing process
11/08/2006	CN1283793C Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
11/08/2006	CN1283774C Wine of aloe lotus seed
11/08/2006	CN1283662C Antagonistic anti-hFAS ligand human antibodies and fragments thereof
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283652C Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
11/08/2006	CN1283641C Pteridine derivatives with nitric oxide synthase inhibitor function
11/08/2006	CN1283281C Medicinal composition containing wild jujube seed, lucid ganoderma and ginseng leaf and its preparing process and use
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132285 Extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells to patient; T-cell- mediated and inflammatory disorders
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006	US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/02/2006	WO2006115509A2 Small molecule immunopotentiators and assays for their detection
11/02/2006	WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115136A1 Allergy-suppressive composition, allergy-suppressive food and allergy-suppressive agent
11/02/2006	WO2006114333A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
11/02/2006	WO2006086500A3 Compositions and methods for treating vascular, autoimmune and inflammatory diseases
11/02/2006	WO2006086498A3 Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
11/02/2006	WO2006081822A3 Minor allergen control to increase safety of immunotherapy
11/02/2006	WO2005113515A8 Pyrimidines for use as plk inhibitors
11/02/2006	WO2005107748A3 Method of tonic treatment with oxyphenbutazone derivatives
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247271 Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23
11/02/2006	US20060247269 Thienopyridone derivatives as kinase inhibitors
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247258 Use of levocetirizine for the treatment of persistent allergic rhinitis
11/02/2006	US20060247241 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247226 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247183 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
11/02/2006	US20060246587 Methods for transfecting T cells
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	US20060246047 Peptide wirh apoptosis-inhibiting activity
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246038 Method of treating a disorder by suicide gene therapy
11/02/2006	US20060246012 Delivery of physiologically active compounds through an inhalation route
11/02/2006	US20060246011 Delivery of diphenhydramine through an inhalation route
11/02/2006	US20060243276 Methods for treating rhinitis and conjunctivitis
11/02/2006	EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1716863A1 T cell immune response inhibitor
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716178A1 Less immunogenic binding molecules
11/02/2006	EP1716158A2 Silinane compounds as cysteine protease inhibitors
11/02/2006	EP1716113A1 Ep2- receptor agonists
11/02/2006	EP1715892A2 Methods and compositions for modulating angiogenesis
11/02/2006	EP1501565B1 Compounds and method for coating surfaces in a haemocompatible manner
11/02/2006	EP1341809B1 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
11/02/2006	EP1296923B1 Aspirin-triggered lipid mediators
11/02/2006	EP1219596B1 Salicylamide derivatives
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
11/02/2006	EP0719331B1 Eotaxin = eosinophil chemotactic cytokine
11/02/2006	CA2609788A1 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
11/02/2006	CA2605756A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	CA2604999A1 Toxin peptides with extended blood halflife
11/02/2006	CA2571710A1 Small molecule immunopotentiators and assays for their detection
11/01/2006	CN1856568A Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract
11/01/2006	CN1856464A 氨基链烷醇衍生物 Amino alkanol derivative
11/01/2006	CN1856325A Treatment of respiratory diseases with anti-IL-2 receptor antibodies
11/01/2006	CN1856323A Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
11/01/2006	CN1856322A Microsome vaccine
11/01/2006	CN1856302A Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir)

1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 1172